BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
102 hedge funds and large institutions have $1.19B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 33 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
+2
Holders Change %
+2%
% of All Funds
2.34%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.14%
New
17
Increased
37
Reduced
33
Closed
15
Calls
$18.4M
Puts
$3.19M
Net Calls
+$15.3M
Net Calls Change
-$47.6M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$38.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$33.4M |
| 3 |
JPMorgan Chase & Co
New York
|
+$20.1M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$16.2M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$13.6M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$18.6M |
| 2 |
GTC
Ghost Tree Capital
New York
|
-$14.2M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$9.37M |
| 4 |
PA
Perceptive Advisors
New York
|
-$7.26M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$4.19M |
